The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 258.30
Bid: 258.30
Ask: 258.50
Change: 0.00 (0.00%)
Spread: 0.20 (0.077%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 258.30
MKS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

9 Dec 2022 15:27

RNS Number : 2713J
Marks and Spencer Group PLC
09 December 2022
 

Director/PDMR Shareholding

 

Marks and Spencer Group plc (the 'Company') announces that on 9 December 2022 it was notified of the following transactions in the Company's Ordinary 1p shares undertaken by directors / persons discharging managerial responsibility ('PDMRs'):

 

1. Performance Share Plan Award 2022/23

The Performance Share Plan ('PSP') continues to be the Company's primary long-term incentive plan for executives. As a result, an award of 859,537 shares under the PSP was made on 9 December 2022 to an incoming PDMR of the Company, Alex Freudmann, Managing Director, Food.

 

As with the awards granted on 5 July 2022 to our other PDMRs, this award has been granted as conditional shares, the vesting of which is subject to the continued employment of the participant and satisfaction of certain performance conditions, as disclosed in the Company's 2022 Annual Report published on 7 June 2022. Specifically, the vesting of the award will depend on relative Total Shareholder Return (TSR), the Company's Earnings Per Share (EPS), Return on Capital Employed (ROCE) and strategic measures over a fixed three-year performance period starting on the first day of the financial year in which the award was granted.

 

On vesting, the award is subject to an additional, mandatory two-year holding period, making a total period of five years post grant. The value of dividends accrued, in the form of dividend equivalents, will be paid at the end of the period (third anniversary) based on the number of vested shares. No consideration was paid for the grant of the award. For the purposes of this award, a share price of £1.3961 was used, being the five-day average share price immediately preceding the July grant date of 5 July 2022.

 

2. Restricted Share Plan Award

Alex Freudmann has also been granted an award of conditional shares under the Company's Restricted Share Plan ('RSP'). This award compensates, on a fair value basis, the share awards forfeited on resigning from his role with Endeavour Group. The fair value has been calculated to take account of the original performance period and the estimated satisfaction of the performance conditions of the original awards. The original vesting timeline for the first tranche of this award has been extended by eight months. The vesting of the final tranche of the award has been aligned to the Company's 2021 PSP awards and is subject to satisfaction of the same performance conditions, as disclosed in the Company's 2021 Annual Report published on 2 June 2021.

 

The value of dividends accrued, in the form of dividend equivalents, will be paid on the vesting date based on the number of vested shares. No consideration was paid for the grant of the award and no price is payable on the exercise of the award. The Company requires Alex Freudmann to have an equity position equivalent to 100% of salary within 5 years of appointment. For the purposes of this award, the five-day average share price immediately preceding the date of grant of £1.2227 was used for the first tranche. For the final tranche of the award, a share price of £1.5267 was used, being the five-day average share price immediately preceding the 2021 PSP grant date of 29 June 2021.

 

Conditional RSP shares granted

Vesting Date

397,480

25 March 2024

655,007

28 June 2024

 

3. Restricted Share Plan Vesting

Vesting of an award granted on 6 July 2020 to Stuart Machin under the Company's Restricted Share Plan ('RSP'), and subsequent sale of shares to satisfy the tax and National Insurance liabilities arising as set out below.

 

The award, as previously announced on 6 July 2020, was a conditional share award of 100,000 shares vesting in two tranches over three years, subject to Stuart's continued employment with the Company. This vesting is the first of the two tranches. Following his appointment in May 2022 as CEO, the Company requires Stuart Machin to have an equity position equivalent to 250% of salary within 5 years of appointment.

 

PDMR

 

 

Shares vested on 9 December 2022

Shares sold to cover tax and NI

Shares retained by individual

S Machin

50,000

23,801

26,199

 

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulations.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

A Freudmann

2

Reason for the notification

a)

Position/status

PDMR (Managing Director, Food)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 1p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

1. Award of conditional shares pursuant to the Marks and Spencer Group Performance Share Plan

2. Award of conditional shares pursuant to the Marks and Spencer Group Restricted Share Plan

c)

Price(s) and volume(s)

1. PSP

Price(s)

Volume(s)

Nil-cost

859,537

2. RSP

Price(s)

Volume(s)

Nil-cost

1,052,487

d)

Aggregated information

-

Aggregated volume

-

Price

1. PSP

Price(s)

Volume(s)

Total

Nil-cost

859,537

 £0.00

2. RSP

Price(s)

Volume(s)

Total

Nil-cost

1,052,487

 £0.00

e)

Date of the transaction

2022-12-09

f)

Place of the transaction

Grant of conditional shares occurred outside a trading venue

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

S Machin

2

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 1p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

3. Vesting of 50,000 shares awarded under the Restricted Share Plan.

4. Subsequent sale of 23,801 shares acquired under the RSP award to cover the tax and NI liability, with 26,199 shares retained.

c)

Price(s) and volume(s)

3. Vesting

Price(s)

Volume(s)

£0.01

50,000

4. Sale

Price(s)

Volume(s)

£1.226729

23,801

d)

Aggregated information

-

Aggregated volume

-

Price

3. Vesting

Price(s)

Volume(s)

Total

£0.01

50,000

 £500.00

4. Sale

Price(s)

Volume(s)

Total

£1.226729

23,801

 £29,197.38

e)

Date of the transaction

2022-12-09

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUBDDXDGDGDC
Date   Source Headline
1st May 20249:00 amRNSTotal Voting Rights
30th Apr 20241:13 pmRNSDirector/PDMR Shareholding
2nd Apr 20249:00 amRNSTotal Voting Rights
28th Mar 20245:23 pmRNSHolding(s) in Company
28th Mar 20243:07 pmRNSDirector/PDMR Shareholding
26th Mar 20243:07 pmRNSDirector/PDMR Shareholding
7th Mar 20243:16 pmRNSHolding(s) in Company
7th Mar 20248:40 amRNSKatie Bickerstaffe - Planned Leadership Evolution
4th Mar 20243:11 pmRNSDirector/PDMR Shareholding
1st Mar 20249:00 amRNSTotal Voting Rights
28th Feb 20241:43 pmRNSDirector/PDMR Shareholding
16th Feb 20249:00 amRNSDirector Declaration
1st Feb 20249:00 amRNSTotal Voting Rights
30th Jan 20242:53 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
15th Jan 20242:36 pmRNSHolding(s) in Company
11th Jan 20247:00 amRNSChristmas 2023/2024 Trading
10th Jan 20243:28 pmRNSChange To Board Committee Membership
5th Jan 20244:23 pmRNSHolding(s) in Company
2nd Jan 20249:00 amRNSTotal Voting Rights
2nd Jan 20249:00 amRNSBlock listing Interim Review
28th Dec 202311:40 amRNSDirector/PDMR Shareholding
20th Dec 202311:36 amRNSHolding(s) in Company
19th Dec 202310:30 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSAdditional Listing
12th Dec 20239:13 amRNSDirector/PDMR Shareholding
1st Dec 20239:00 amRNSTotal Voting Rights
28th Nov 20232:55 pmRNSDirector/PDMR Shareholding
9th Nov 202310:29 amRNSDirector/PDMR Shareholding
8th Nov 20237:00 amRNSHalf-year Report
1st Nov 20239:00 amRNSTotal Voting Rights
30th Oct 20235:01 pmRNSDirector/PDMR Shareholding
2nd Oct 20239:00 amRNSTotal Voting Rights
28th Sep 20233:18 pmRNSDirector/PDMR Shareholding
20th Sep 20233:33 pmRNSHolding(s) in Company
20th Sep 20239:00 amRNSDirector/PDMR Shareholding
19th Sep 20239:01 amRNSDirector/PDMR Shareholding
1st Sep 20239:00 amRNSTotal Voting Rights
30th Aug 202310:34 amRNSDirector/PDMR Shareholding
16th Aug 20233:00 pmRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSTrading Update and Outlook for the Year
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 202311:33 amRNSDirector/PDMR Shareholding
7th Jul 20234:18 pmRNSDirector/PDMR Shareholding
4th Jul 20232:13 pmRNSResult of AGM
3rd Jul 20239:00 amRNSTotal Voting Rights
3rd Jul 20239:00 amRNSBlock listing Interim Review
28th Jun 20232:01 pmRNSDirector/PDMR Shareholding
19th Jun 20234:41 pmRNSDirector/PDMR Shareholding
8th Jun 20235:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.